PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Health Catalyst, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Health Catalyst, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Cash Cushion Ratio: Debt, after subtracting cash, equals 58% of its market value (net debt). Lower than 93% of Healthcare companies in United States.
  • Growth Efficiency Ratio: Sales grew 13% in 3 years, but profit fell: $116 less profit per $100 of extra sales. Lower than 88% of Healthcare companies in United States.
  • Tangible Assets Ratio: Of every $100 the company owns, $43 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 86% of Healthcare companies in United States.

Where $100 of sales goes

$114Operating costs$7.8Interest$57Net loss

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

-0.3×

Over the last 3 years operating cash was negative while the company kept spending on investment (capex).

Higher than 62% of Healthcare companies in United States.

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

3/3 · 2/3

Sales grew in 3 of the last 3 years; profit grew in 2 of 3.

Steadier than 85% of Healthcare companies in United States.

Growth Efficiency Ratio

−$116

Sales grew 13% in 3 years, but profit fell: $116 less profit per $100 of extra sales.

Lower than 88% of Healthcare companies in United States.

Asset Productivity Ratio

+13% / -33%

In 3 years sales changed by +13% while total assets changed by -33%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

0.4×

Debt due within a year is covered 0.4 times by its yearly operating cash.

Higher than 70% of Healthcare companies in United States.

Cash Cushion Ratio

−58%

Debt, after subtracting cash, equals 58% of its market value (net debt).

Lower than 93% of Healthcare companies in United States.

Tangible Assets Ratio

43%

Of every $100 the company owns, $43 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 86% of Healthcare companies in United States.

Tangible Net Worth Ratio

Negative

Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.

Less tangible than 78% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+30%

Share count rose 30% in 3 years, so each share's slice of the company became smaller.

Smaller rise in share count than 51% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

Health Catalyst, Inc. made a loss over the last year. Health Catalyst, Inc. owes $0.72 for every $1 it owns. Health Catalyst, Inc. made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

Health Catalyst, Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

1.30

The share price is 1.30 times Health Catalyst, Inc.'s book value per share, lower than 73% of Healthcare companies in United States.

Market cap

$131 M

The total market value of all of Health Catalyst, Inc.'s shares at today's price (share price × number of shares), smaller than 63% of Healthcare companies in United States. PosiCap size class: Mini Cap.

Net worth (book value)

$101 M

What Health Catalyst, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$1.34

Net worth divided by the number of shares. The share price of $1.74 is 1.3 times this, which is the P/B above.

Return on equity (ROE)

-118.1%

Health Catalyst, Inc. lost 118.1% of its shareholders' money over the last year, lower than 75% of Healthcare companies in United States.

Owes vs Owns

0.72×

Health Catalyst, Inc. owes $0.72 for every $1 it owns (moderate), higher than 73% of Healthcare companies in United States.

Dividend yield

None

Health Catalyst, Inc. does not currently pay a dividend.

Revenue growth

+1%

Revenue rose 1% in the year to Dec 2025, and grew 4% a year on average over 3 years.

Profit growth

Loss

Health Catalyst, Inc. made a loss in each of the last two years.

Profit margin

-57.2%

Health Catalyst, Inc. lost $57 for every $100 of revenue.

Interest cover

Not covered

Health Catalyst, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net debt

Health Catalyst, Inc. had $76 M more debt than cash (net debt) at Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Health Catalyst, Inc.: $131 M ÷ $101 M (30 Jun 2026) = 1.3.

What is Health Catalyst, Inc.'s return on equity?

Health Catalyst, Inc. lost 118.1% of its shareholders' money over the last year, lower than 75% of Healthcare companies in United States.

How much does Health Catalyst, Inc. owe compared with what it owns?

Health Catalyst, Inc. owes $0.72 for every $1 it owns (moderate), higher than 73% of Healthcare companies in United States.

Does Health Catalyst, Inc. pay a dividend?

No. Health Catalyst, Inc. does not currently pay a dividend.

Is Health Catalyst, Inc.'s revenue growing?

Revenue rose 1% in the year to Dec 2025, and grew 4% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.